General Information of the Compound
Compound ID
CP0092719
Compound Name
1-(2-(pyridin-4-yl)ethyl)-N-(quinolin-3-yl)-1H-pyrazole-5-carboxamide
    Show/Hide
Structure
Formula
C20H17N5O
Molecular Weight
343.39
Canonical SMILES
O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1
    Show/Hide
InChI
InChI=1S/C20H17N5O/c26-20(24-17-13-16-3-1-2-4-18(16)22-14-17)19-7-11-23-25(19)12-8-15-5-9-21-10-6-15/h1-7,9-11,13-14H,8,12H2,(H,24,26)
    Show/Hide
InChIKey
UXBBSNXOJUJAHD-UHFFFAOYSA-N
Physicochemical Property
logP
3.3213
Rotatable Bonds
5
Heavy Atom Count
26
Polar Areas
72.7
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44431907
ChEMBL ID
CHEMBL391069
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 1220 nM
   TI
   LI
   LO
   TS